The golden line of HIV!

Another name for long-term panic is the HIV virus. After many studies, nothing has matched the right antidote. But this time, researchers are probably seeing the golden line of success. They claim that the success rate of this HIV vaccine is 98 percent.

The human trial of this new ticker is going on. And it has been shown that it is able to awaken extremely rare immune cells in the human body. It is claimed that these cells build up immunity in the human body against this deadly virus.

The vaccine was developed by scientists at the Scripps Research Institute in San Diego, USA, and IVI, a non-profit organization. The Scripps Research Institute said on Wednesday that the vaccine had been administered to 48 people in the first phase.

The results of the study were later announced at a virtual conference. It was reported that the study was successful in 98 percent of the cases. The "messenger mRNA" technology used by Pfizer or the Pfizer company to develop the covid vaccine is also known to have been used in this case.

Shafat Mahmud Shaan

Information Dept. Executive,BYAAA

ahmud Shaan Information Dept. Executive, BYAAA